Jove
Visualize
Contact Us

Related Concept Videos

Drug Dependence01:17

Drug Dependence

1.9K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.9K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

1.6K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.6K
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

600
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
600
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

1.4K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.4K
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

1.6K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.6K
Cognitive Development During Adolescence01:18

Cognitive Development During Adolescence

976
During adolescence, individuals experience significant cognitive development that enhances their understanding of others' emotions and thoughts, known as cognitive empathy. This period is marked by an increased ability to adapt to others' perspectives and a more nuanced understanding of others' mental states, a skill that is foundational for social problem-solving and conflict avoidance. The development of cognitive empathy relies heavily on the theory of mind — the...
976

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex differences in stress responding in a randomized, placebo-controlled clinical trial of progesterone in cannabis use disorder.

Psychopharmacology·2026
Same author

Medication Samples and Smoking Cessation Among Adults: A Randomized Clinical Trial.

JAMA network open·2026
Same author

Determining the impact of cannabis use on tobacco cessation: Results from a prospective non-randomized tobacco treatment trial.

Addiction (Abingdon, England)·2026
Same author

Defining Entrants Into the Child and Adolescent Psychiatry Workforce in the United States: Match Results From 2009 to 2025.

Journal of the American Academy of Child and Adolescent Psychiatry·2026
Same author

Varenicline for cannabis use disorder: A randomized controlled trial.

Addiction (Abingdon, England)·2026
Same author

Social Determinants of Health and Pediatric Long COVID in the US.

JAMA pediatrics·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 22, 2026

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.3K

New Developments in Understanding and Treating Adolescent Marijuana Dependence.

Kevin M Gray

    Adolescent Psychiatry (Hilversum, Netherlands)
    |October 8, 2014
    PubMed
    Summary

    Adolescent marijuana use is rising, with significant adverse outcomes. While psychosocial interventions help reduce use days, achieving abstinence remains challenging, necessitating further research and novel treatments like N-acetylcysteine.

    Keywords:
    AdolescentsN-acetylcysteinecannabis dependencemarijuana dependencemarijuana use disorderstreatment

    More Related Videos

    Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
    07:30

    Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

    Published on: August 18, 2020

    8.4K
    Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
    06:09

    Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

    Published on: May 30, 2025

    907

    Related Experiment Videos

    Last Updated: Apr 22, 2026

    Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
    07:51

    Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

    Published on: August 1, 2025

    1.3K
    Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
    07:30

    Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

    Published on: August 18, 2020

    8.4K
    Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
    06:09

    Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

    Published on: May 30, 2025

    907

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Public Health

    Background:

    • Marijuana is the most prevalent illicit substance globally.
    • Adolescent marijuana use presents a growing public health concern with associated adverse outcomes.
    • Substance use initiation commonly occurs during adolescence.

    Purpose of the Study:

    • To review trends in marijuana use and its neurobiological underpinnings.
    • To examine policy changes in the US and their impact on adolescent use.
    • To evaluate current and novel treatment strategies for marijuana use disorder.

    Main Methods:

    • Overview of marijuana use trends and the endocannabinoid system.
    • Discussion of US policy developments and adolescent implications.
    • Review of existing treatments, including a trial of N-acetylcysteine for substance dependence.

    Main Results:

    • Psychosocial interventions can reduce marijuana use days but rarely achieve abstinence.
    • N-acetylcysteine shows promise in addressing glutamate dysregulation in substance dependence.
    • Current evidence for effective adolescent marijuana use treatments is limited.

    Conclusions:

    • Effective treatment for adolescent marijuana use disorder requires further research.
    • Combination therapies, such as N-acetylcysteine with contingency management, show potential.
    • Addressing the growing problem of adolescent marijuana use necessitates innovative therapeutic approaches.